The osteoclast-targeted therapy is a potential method to address the development of osteosarcoma.[35] Thus, the involvement of TYROBP in the osteoclast differentiation pathway might partially explain that high TYROBP expression contributed to better OS of osteosarcoma patients. Here, TYROBP is linked to osteosarcoma.